Back to Authors

Shetty, Sindhu

https://orcid.org/0000-0001-5484-790X

Mayo Clinic

Cleveland Clinic

Citations 2

Bone and soft tissue sarcomas in cerebrospinal fluid and effusion: A 20‐year review at our institution
Sharma, Anurag , Thangaiah, Judith Jebastin, Shetty, Sindhu , Policarpio‐Nicolas, Maria Luisa , Policarpio-Nicolas, Maria Luisa C

Cancer Cytopathology | July 7, 2021 | Volume: 129 | Issue: 10 | Pages: 776-787

10.1002/cncy.22431 Get It

BackgroundThe literature on bone and soft tissue sarcomas (BSTSs) involving effusions and cerebrospinal fluid (CSF) is very limited.MethodsA computerized search for fluid cytology with a sarcoma diagnosis from 2000 to 2020 was performed. All available cases, including the clinical follow‐up, were reviewed.ResultsA total of 57 fluids specimens from 36 BSTSs were identified (9 rhabdomyosarcomas, 6 angiosarcomas, 5 epithelioid hemangioendotheliomas, 3 dedifferentiated liposarcomas, 2 chondrosarcomas, 1 extraskeletal myxoid chondrosarcoma, 3 Ewing sarcomas, 2 undifferentiated sarcomas, 3 osteosarcomas, 1 synovial sarcoma, and 1 hybrid low‐grade fibromyxoid sarcoma/sclerosing epithelioid fibrosarcoma). There were 22 males and 14 females. The age range was 4 to 82 years (median, 45 years). Sites of involvement included pleural fluid (n = 38), peritoneal fluid (n = 14), and CSF (n = 5). Twenty‐four cytology cases were available for review. The cytologic features were nonspecific and ranged from dyshesive to clusters of round, epithelioid, pleomorphic, and occasionally spindle‐shaped malignant cells that could easily mimic other non‐BSTS malignant tumors. The diagnosis of BSTS was made by comparison with a prior specimen and/or ancillary studies (molecular or immunohistochemical stains). The prognosis was poor because 95% of the patients died of their disease.ConclusionsThe incidence of BSTS in fluid cytology is extremely rare, and it can have cytologic features similar to those of non‐BSTS malignancies. Although, in most cases, a comparison with a prior known BSTS specimen may suffice, the use of ancillary studies is extremely helpful in arriving at the correct diagnosis. However, in cases with no known prior malignancy, including BSTS in the differential diagnosis is prudent for preventing misdiagnosis.
Mammary Extranodal Rosai-Dorfman Disease With and Without Associated Axillary Lymphadenopathy: Insights for Practitioners of Breast Pathology
Shetty, Sindhu , Sharma, Nidhi , Booth, Christine N. , Oshilaja, Olaronke , Downs‐Kelly, Erinn, McKenney, Jesse K. , Sturgis, Charles D.

International Journal of Surgical Pathology | January 29, 2020 | Volume: 28 | Issue: 5 | Pages: 541-548

10.1177/1066896920901770 Get It

Rosai-Dorfman disease is a rare proliferative histiocytic disorder of lymph nodes that is descriptively known as sinus histiocytosis with massive lymphadenopathy. Extranodal involvement of the parenchyma of the breast is uncommonly reported, with fewer than 50 cases of mammary extranodal disease detailed in the English-language literature. We characterize a retrospective series of adult female patients from a single institution with Rosai-Dorfman disease of the breast and axillary lymph nodes. Because Rosai-Dorfman disease of the breast and axillary lymph nodes may clinically, radiographically, and histologically mimic breast carcinoma and other conditions, we present an illustrated review of the disease and its relevant differential diagnoses in hopes of raising awareness and allowing for accurate management of affected patients.